Personalized cancer vaccines: CureVac acquires oncology startup
CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform
10-Jun-2022 -
CureVac N.V. announced its acquisition of Frame Cancer Therapeutics, a private company focused on advanced genomics and bioinformatics to identify both unique and shared neoantigens across different cancer types.
“The addition of Frame’s technology and talent to CureVac’s oncology research ...
acquisitions
cancer
cancer vaccines
+2